Advertisement
For patients undergoing elective cancer surgery

COVID-19-Free Surgical Pathways May Aid Cancer Surgery Outcomes

0
Pulmonary complication, postoperative SARS-CoV-2 infection rates lower with COVID-19-free pathways
The number of expected U.S. deaths increased considerably from March through July 2020

U.S. Deaths Up 20 Percent From March Through July 2020

0
The United States has had high COVID-19-associated mortality compared with other countries
Bedside open tracheotomy seems safe for critically ill patients with COVID-19

Bedside Tracheotomy Feasible for Critically Ill COVID-19 Patients

0
No infection identified among surgeons following procedure; postoperative complications rarely seen
COVID-19 deaths in the United States could reach 233

CDC: U.S. COVID-19 Deaths Could Reach 233,000 by End of October

0
And, dual coronavirus-flu vaccine to start human trials
For patients hospitalized with COVID-19

Remdesivir Cuts Time to COVID-19 Recovery

0
However, no significant difference in mortality found between remdesivir and placebo groups
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 5 to 9

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Patients using QT-prolonging drugs have an increased risk for cardiac events in association with azithromycin versus amoxicillin

Some Patients Have Increase in Cardiac Events With Azithromycin

0
Risk for cardiac events higher with azithromycin versus amoxicillin in those using QT-prolonging drugs
The lifetime prevalence of suicide ideation is 17.4 percent among physicians

Lifetime Prevalence of Suicide Ideation 17.4 Percent Among Doctors

0
Lifetime prevalence of suicide attempts 1.8 percent, with one-year prevalence of 0.3 percent
Regeneron Pharmaceuticals Inc. said Wednesday that it is seeking emergency approval from the U.S. Food and Drug Administration for an experimental antibody cocktail given to President Donald Trump shortly after he was diagnosed with COVID-19.

Maker of Antibody Cocktail Trump Took Seeks Emergency Use Authorization

0
Although effectiveness has not yet been seen in humans, drug has shown promise in treating mild cases of COVID-19
Neurologic manifestations are common in COVID-19

Neurologic Manifestations Seen in Most Hospitalized With COVID-19

0
Encephalopathy, seen in 31.8 percent of hospitalized patients, tied to worse functional outcome, mortality